Every record from Janoshik · page 23
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041696 | Semaglutide | QSC | QSC-2508-F9226 | 2026-Q1 | 98.94 | 4.92 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041632 | Semaglutide | QSC | QSC-2602-G8557 | 2026-Q1 | 99.04 | 4.33 | 93.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041572 | Pramlintide | QSC | QSC-2511-T6680 | 2026-Q1 | 99.37 | 5.63 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043566 | Tirzepatide | BCH | BCH-2601-N7656 | 2026-Q1 | 98.39 | 3.75 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042873 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 99.53 | 3.77 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042770 | Ipamorelin | GGPeps | GGPE-2508-E9990 | 2026-Q1 | 99.53 | 4.41 | 98.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042509 | Semax | ERP | ERP-2512-G6974 | 2026-Q1 | 99.93 | 8.75 | 96.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042079 | BPC-157 | TFC | TFC-2512-L7022 | 2026-Q1 | 98.78 | 6.01 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-041870 | CJC-1295 with DAC | JEEP | JEEP-2601-V2811 | 2026-Q1 | 99.44 | 3.63 | 104.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043432 | MOTS-c | WXT | WXT-2512-K4589 | 2026-Q1 | 97.92 | 2.47 | 90.0 | Supplier-supplied | 1 | FAIL |
| AX-2026-042835 | BPC-157 | GGPeps | GGPE-2512-N1746 | 2026-Q1 | 99.29 | 6.90 | 106.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042494 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.75 | 4.62 | 96.8 | Laboratory-retained | 0 | PASS |
| AX-2026-042719 | Retatrutide | GGPeps | GGPE-2511-W9618 | 2026-Q1 | 97.69 | 5.57 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041996 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 98.63 | 3.92 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041678 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.78 | 6.29 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041567 | Pramlintide | QSC | QSC-2511-T6680 | 2026-Q1 | 98.73 | 5.07 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043545 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.02 | 4.02 | 96.7 | Supplier-supplied | 1 | FAIL |
| AX-2026-043411 | Tesamorelin | WXT | WXT-2601-A4454 | 2026-Q1 | 97.05 | 3.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043310 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.15 | 7.85 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-043159 | Retatrutide | SSA | SSA-2601-T7702 | 2026-Q1 | 98.75 | 5.38 | 91.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042307 | Tirzepatide | HJ | HJ-2508-P3416 | 2026-Q1 | 98.50 | 4.11 | 88.9 | Supplier-supplied | 4 | MARGINAL |
| AX-2026-041340 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.93 | 6.19 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043556 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.30 | 3.61 | 88.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-043505 | TB-500 | BCH | BCH-2509-E6436 | 2026-Q1 | 98.90 | 3.39 | 92.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043347 | BPC-157 | CPC | CPC-2510-R2456 | 2026-Q1 | 98.22 | 8.25 | 103.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042453 | MGF | SWB | SWB-2601-E6319 | 2026-Q1 | 98.32 | 4.40 | 91.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042008 | Epitalon | TFC | TFC-2508-W5644 | 2026-Q1 | 99.07 | 6.76 | 89.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041990 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 99.30 | 3.63 | 101.1 | Supplier-supplied | 0 | PASS |
| AX-2026-041473 | AOD-9604 | QYB | QYB-2508-E6017 | 2026-Q1 | 99.32 | 4.06 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043171 | Tirzepatide | GL Biochem | GLBI-2510-N7925 | 2026-Q1 | 97.69 | 3.33 | 89.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042877 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 99.49 | 3.74 | 91.9 | Supplier-supplied | 0 | FAIL |
| AX-2026-042720 | Retatrutide | GGPeps | GGPE-2511-W9618 | 2026-Q1 | 97.65 | 6.02 | 96.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042402 | Semaglutide | SWB | SWB-2512-L5147 | 2026-Q1 | 97.07 | 4.43 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042232 | Semax | Homopeptide | HOMO-2512-Y1524 | 2026-Q1 | 99.43 | 7.92 | 97.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041679 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.73 | 6.03 | 107.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043559 | MOTS-c | BCH | BCH-2601-U7218 | 2026-Q1 | 98.40 | 5.76 | 93.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042841 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 97.78 | 6.34 | — | Laboratory-retained | 2 | FAIL |
| AX-2026-042255 | CJC-1295 (no DAC) | Homopeptide | HOMO-2512-D1150 | 2026-Q1 | 99.93 | 5.09 | 95.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043375 | Gonadorelin | CPC | CPC-2508-B3242 | 2026-Q1 | 99.17 | 4.36 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042924 | Semaglutide | MKM | MKM-2508-R2718 | 2026-Q1 | 98.97 | 5.04 | — | Supplier-supplied | 1 | MARGINAL |